Q2 2026 saw 5% organic sales growth, 28% order growth, and 12% adjusted EPS growth, with strong performance in HST and robust demand in data center, semiconductor, and space/defense. Full-year guidance was raised for organic growth, margins, and EPS, supported by a growing backlog and increased Cap…
IDEX Corporation NYSE:IEX today announced its financial results for the three-month period ended June 30, 2026.Said CEO Eric Ashelman, “We are very pleased to see continued results momentum as our IDEX teams drove another quarter of strong sales and earnings growth. Orders of over $1 billion in the…
Record sales and orders drove double-digit EPS growth, with strong performance in Health & Science Technologies and robust cash flow. Full-year guidance was raised on the back of broad-based demand and margin expansion, despite some segmental softness.Original document: IDEX Corporation [IEX] SEC 8…
Manufacturing company IDEX NYSE:IEXwill be reporting results this Wednesday before market hours. Here’s what investors should know.IDEX beat analysts’ revenue expectations last quarter, reporting revenues of $886.9 million, up 8.9% year on year. It was a strong quarter for the company, with a solid…
